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Background: Glucocorticoids exert recognized positive effects on lung development. The genes involved in the
classical pathway of glucocorticoid synthesis normally occurring in adrenals were found to be expressed on
gestation day (GD) 15.5 in the developing mouse lung. Recently, expression of two of these genes was also
detected on GD 17.5 suggesting a more complex temporal regulation than previously expected. Here, we deepen
the knowledge on expression of “adrenal” glucocorticoid synthesis genes in the mouse lung during the perinatal
period and we also study expression of the gene encoding for the steroid inactivating enzyme 20α-hydroxysteroid
dehydrogenase (20α-HSD).
Results: We performed an ontogenic study of P450scc, 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase 1 (3β-HSD1),
21-hydroxylase, 11β-hydroxylase, 11β-HSD1, and 11β-HSD2 expression up to post natal day (PN) 15. The substrate
(progesterone) and the product (deoxycorticosterone) of 21-hydroxylase are substrates of 20α-HSD, thus 20α-HSD
(Akr1c18) gene expression was investigated. In lung samples collected between GD 15.5 and PN 15, 11β-hydroxylase
was only detected on GD 15.5. In contrast, all the other tested genes were expressed throughout the analyzed period
with different temporal expression patterns. P450scc, 21-hydroxylase, 20α-HSD and 11β-HSD2 mRNA levels
increased after birth with different patterns including an increase from PN 3 with a possible sex difference for
21-hydroxylase mRNA. Also, the 21-hydroxylase protein was observed by Western blot in perinatal lungs with
higher levels after birth.
Conclusion: Progesterone is present at high levels during gestation and the product of 21-hydroxylase,
deoxycorticosterone, can bind the glucocorticoid receptor with an affinity close to that of corticosterone. Detection of
21-hydroxylase at the protein level during antenatal lung development is the first evidence that the adrenal-like
glucocorticoid synthesis pathway detected during lung development has the machinery to produce glucocorticoids in
the fetal lung. Glucocorticoids from lung 21-hydroxylase appear to modulate lung ontogenesis through paracrine/
intracrine actions.
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Glucocorticoids (GCs) play an essential role in fetal lung
development [1,2]. They exert various effects including
thinning of alveolar septa, increase in the number of
type I pneumonocytes, decrease in pneumonocyte cell
division, and stimulation of secretion of fibroblast para-
crine factors that play a role in type II pneumonocyte
maturation [3]. Glucocorticoid receptor-deficient mice
were reported to die within a few hours after birth be-
cause of respiratory failure [4], showing the importance
of GCs in the lung development process. The require-
ment for GCs in normal lung development was also
demonstrated with a CRH knockout (KO) mouse model.
CRH KO homozygous fetuses from CRH KO homozy-
gous mothers were delivered normally at term, but died
on the first day of life with an overall failure in lung de-
velopment, except when GCs were administered to preg-
nant dams [2,5]. The overall failure of lung development
was characterized by hypercellularity of the mesenchy-
mal compartment and decreased expression of mRNAs
associated with mature lung epithelial cells such as those
of surfactant protein (SP)-A, SP-B and CCP10.
The endogenous GCs accessible to the developing
lung originate from two sources. They can be provided
by adrenals through the classical pathway of GC synthesis
from cholesterol, or by the lung where cortisone or 11-
dehydrocorticosterone (11-DHC, rodent) can be reactivated
to cortisol or corticosterone, respectively. In the rodent ad-
renals, cytochrome P450 side-chain cleavage (P450scc), 3β-
hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase (3β-HSD),Figure 1 Glucocorticoid synthesis pathway in rodent and non-rodent
are the most potent circulating GCs. Their production from cholesterol in adre
P450c17 enzyme in the rodent adrenal. Cell-specific 11β-HSD-catalyzed reactio
or all the enzymes catalyzing GC production from cholesterol has been obser21-hydroxylase, and 11β-hydroxylase are involved in GC
synthesis (Figure 1). All these enzymes play a similar role in
the adrenals of the human and many other non-rodent
mammals, except that cytochrome P450c17 converts preg-
nenolone and progesterone into 17OH-pregnenolone and
17OH-progesterone, respectively. This leads to the pro-
duction of the active GC cortisol instead of cortico-
sterone. In peripheral tissues including the lung, GC
synthesis was considered for many years to be limited
to cortisol (human) and corticosterone (rodents) re-
activation by 11β-hydroxysteroid dehydrogenase type 1
(11β-HSD1) [6] following their prior inactivation by
11β-HSD2. This perception is changing since genes nor-
mally involved in the classical adrenal pathway of GC
synthesis were found to be expressed in some peripheral
sites such as thymus, skin, and brain [7]. We are among
the pioneers that have described expression of the ad-
renal genes outside adrenals [8].
In 2005, we reported that the four genes encoding for
the enzymes catalyzing corticosterone synthesis from
cholesterol and StAR were expressed in the fetal lung on
gestation day (GD) 15.5 in the Balb/c mouse [8]. StAR is
essential to this synthesis pathway since it plays a role
in the intramitochondrial movement of cholesterol [9].
In fetal lungs studied up to GD 18.5, 11β-hydroxylase
mRNA was found only on GD 15.5, which led to the ini-
tial conclusion that the adrenal pathway of GC synthesis
should be expressed only on GD 15.5 in the developing
lung. Further studies showed that 3β-HSD1 and 21-
hydroxylase were still expressed on GD17.5 [10,11]. Thismammals. Corticosterone (rodent) and cortisol (non-rodent mammals)
nals correspond to the classical pathway of GC synthesis. There is no
ns occur in peripheral tissues. During the last decade, expression of some
ved in some non-adrenal tissues including the developing lung.
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oxycorticosterone (DOC), is known to bind the gluco-
corticoid receptor [12-15] with an IC50 value of 70 nM
compared to 60 nM for corticosterone [15]. Therefore,
the impact of 21-hydroxylase on lung development may
be exerted during a longer period, but the exact develop-
mental time remains to be characterized.
The aim of the present study was to deepen the know-
ledge on expression of “adrenal” glucocorticoid synthesis
genes in the mouse lung during the perinatal period and
to study expression of the 20α-HSD gene encoding for a
steroid inactivating enzyme active on c21 steroids. An
ontogenic study of P450scc, 3β-HSD1, 21-hydroxylase,
and 11β-hydroxylase expression in the mouse developing
lung was performed up to post-natal day (PN) 15. Genes
encoding for 11β-HSD1 and 11β-HSD2 were included
for comparison. In addition, the expression of Akr1c18
gene, encoding for 20α-HSD, was included because 20α-
HSD is active on the substrate (progesterone) and on
the product (DOC) of 21-hydroxylase. This gene has
never been studied in the lung. Because a sex difference
in the timing of expression of the adrenal-like pathway
of GC synthesis was proposed on GD 15.5 in the fetal
lung [8], both sexes were studied separately. Finally, an
ontogenic study of levels of 21-hydroxylase protein is
also included.
Results
Expression of genes of the “adrenal” pathway of GC
synthesis in the antenatal lung after GD 15.5 and in the
post-natal developing lung
The temporal and sexual expression profiles of P450scc,
3β-HSD1, 21-hydroxylase, and 11β-hydroxylase genes
were determined using cDNA prepared from pooled
male and female lung tissues (one pool/sex/litter) from
GD 15.5 to PN 15. The 11β-hydroxylase transcript was
detected at significant levels on GD 15.5, but not be-
tween GD 16.5 and PN 15 inclusively (data not shown).
These data are in agreement with previously published
data obtained between GD 15.5 and 18.5 [8,10], and on
GD 17.5 [10]. Conversely, the P450scc, 3β-HSD1 and
21-hydroxylase genes were expressed after GD 15.5 at
least up to PN 15 in the alveolar stage (Figure 2). In fact,
mRNAs were detected for these three genes in all ana-
lyzed samples, exhibiting specific temporal expression
patterns. A two-way ANOVA showed that P450scc mRNA
levels varied significantly according to developmental age,
but not sex (Table 1). In fact, a significant 18-fold increase
was observed from GD 15.5 to GD 19.5, followed by a sig-
nificant 2.3-fold increase between PN 0 and PN 3, and a
marked significant 28-fold decrease from PN 7 to PN 15
(Figure 2A-B). Expression of 3β-HSD1 did not show sig-
nificant temporal or sexual regulation, although a slight
significant trend for decreased expression was observedover developmental time (Figure 2C-D and Table 1). A
statistical analysis showed a significant influence of age
but not of sex or sex*age on 21-hydroxylase expression
(Table 1). Hence, 21-hydroxylase expression was stable
from GD 15.5 to PN 3, presented a 4.3-fold increase be-
tween PN 3 and PN 7, and remained stable until PN 15
(Figure 2E-F). Inter-litter variability was somewhat higher
on PN 7 and PN 15 for 21-hydroxylase, which might ex-
plain why no statistically significant sex difference was
found despite the fact that all the 6 litters of this period
showed higher expression levels for females compared to
males (Figure 2E).
Sexual and temporal regulation of 20α-HSD expression in
the antenatal and post-natal developing lungs
Progesterone and DOC inactivation can be achieved by
20α-HSD activity, which was observed in cytosolic frac-
tions of adult mouse lungs [16] and in adult human lung
slices [17]. However, an ontogenic study of 20α-HSD ex-
pression has never been reported in the developing lung.
To perform this study, 20α-HSD mRNA levels were
measured in mouse developing lung samples collected at
various developmental times. Expression of 20α-HSD
was observed in all samples analyzed from GD 15.5 to
PN 15 (Figure 3). A statistically significant variation over
developmental time was observed (Table 1) including a
marked post-natal increase until PN 3 for both sexes.
While no significant sex difference was detected by two-
way ANOVA, a male-specific decrease of 19-fold before
birth was observed (Figure 3). Expression levels of 20α-
HSD were higher than those of 21-hydroxylase during
near all the developmental period studied, with a differ-
ence of 5.4-fold in favor of 20α-HSD on PN 3.
11β-HSD1 and 11β-HSD2 expression profiles from GD
19.5 to PN 15
A qPCR study of 11β-HSD1 and 11β-HSD2 expression
was reported in the fetal lung between GD 15.5 and 18.5
[8]. Here, the study covers the GD 19.5-PN 15 period.
Only little changes were measured over developmental
time for 11β-HSD1. In contrast, the 11β-HSD2 mRNA
levels presented a marked statistically significant in-
crease after birth (Figure 4 and Table 1).
21-Hydroxylase protein during lung development
The levels of the 21-hydroxylase protein were analyzed
by Western blotting of whole lung protein samples and
of microsomal fractions. Our data show that not only
the 21-hydroxylase mRNA but also the 21-hydroxylase
protein are present in the perinatal lung (Figure 5 and
data not shown). Specific signals were higher in lung
samples collected after birth compared to those obtained
during gestation (Figure 5). Because 21-hydroxylase is a
microsomal protein, microsome preparations were also
Figure 2 Relative expression of P450scc, 3β-HSD1, and 21-hydroxylase genes according to sex and age in the mouse developing lung.
Relative expression values were determined by qPCR for P450scc (A), 3β-HSD1 (C), and 21-hydroxylase (E) in male and female pools of 3 litters
for each age. The results are the mean of 2 PCR reactions (±SD). Then, the mean of expression (± SEM) for each sex and each age was calculated
from the values presented in the histograms and the resulting curves are presented for P450scc (B), 3β-HSD1 (D), and 21-hydroxylase (F).
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protein extracts (Figure 5A) was undetected or close to
the background with microsomal fractions (Figure 5B).
The most intense signals were observed with samples
from PN 7 and PN 16. This increase in 21-hydroxylase
protein levels correlates with the increase in mRNA
levels described above (Figure 2E-F). Intermediate pro-
tein levels were observed in samples from PN 3 (one in-
dividual) and PN 2 (pool from one litter). This can be
explained by slight variations in mRNA levels from indi-
vidual to individual or from litter to litter, as those ob-
served in Figure 2E. No sex difference was observed atthe specific developmental times tested, except on PN
15, when a slight difference in favor of females was ob-
served (data not shown).
Discussion
This is the first ontogenic study performed in the develop-
ing lung up to PN 15 studying expression of the four
genes normally involved in the adrenal pathway of gluco-
corticoid synthesis from cholesterol. 11β-hydroxylase was
previously studied in the developing lung after GD 15.5
(from GD 15.5 to GD 18.5 [8] and on GD 17.5 [10]) and
no detectable levels of 11β-hydroxylase mRNA were found
Table 1 Two-way analysis of variance (ANOVA) of
expression of murine genes involved in C-21 steroid
metabolism in the developing lung
Gene P values
AgexSex Age Sex
P450scc 0.6606 < 0.0001 0.3264
3β-HSD1 0.1387 0.0630 0.6889
21-hydroxylase 0.7968 0.0029 0.2728
20α-HSD 0.3141 0.0003 0.4667
11β-HSD1 0.3073 0.0104 0.8879
11β-HSD2 0.9989 < 0.0001 0.9233
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eral time points from GD 15.5 to PN 15, we conclude that
11β-hydroxylase mRNA can be found only on GD 15.5
in the developing lung. In contrast, P450scc, 3β-HSD1
and 21-hydroxylase mRNAs were found in all the ana-
lyzed samples from GD 15.5 to PN 15. Moreover, the
21-hydroxylase protein was observed in all the analyzed
samples from GD 15.5 to PN 16. This is important
because the substrate of this enzyme, progesterone, is
present during gestation while the product of this en-
zyme, DOC, has the ability to bind the glucocorticoid
receptor [12-15] with an IC50 value of 70 nM compared
to 60 nM for corticosterone [15]. Therefore, the devel-
oping lung possesses the machinery to produce active
glucocorticoids, at least during gestation, using circulat-
ing progesterone as a substrate.
A transient sex difference in 20α-HSD mRNA levels
was observed on GD 19.5 in the developing lung, when
the female values were 19-fold higher than the male
values (Figure 3). A sex difference in 20α-HSD expres-
sion was also reported in the mouse adrenal [18]. In that
tissue, 20α-HSD expression was restricted to the transi-
ent X-zone located between the cortex and the medulla.Figure 3 Relative expression of 20α-HSD according to sex and age in
determined by qPCR for 20α-HSD (A) in male and female pools of 3 litters
the mean of expression (± SEM) for each sex and each age was calculatedThe presence of the 20α-HSD protein in adrenals was
shown to correlate with the presence of the X-zone. On
PN 10, no sex difference was observed in the lung in our
experiments, whereas a sex difference was found in the
adrenal where both 20α-HSD and the X-zone were
absent specifically in the male tissue. Therefore, no rela-
tionship between the sex differences observed in the
developing lung and in adrenals can be established. Sex
differences in 20α-HSD mRNA levels with higher levels
for females were also observed in the skin, liver, and kid-
ney obtained from adult mice [19]. It was suggested that
20α-HSD may play a role in reducing intracellular levels
of progesterone originating from the circulation [19]. In
the lung, except on GD 19.5, no significant sex differ-
ence was observed in 20α-HSD mRNA levels, which is
in line with the absence of sex difference in perinatal
progesterone levels in rodents [20]. However, progester-
one levels are decreasing in late gestation to reach very
low levels after birth, which is not the case for 20α-HSD
expression.
The expression of 20α-HSD in the developing lung is
compatible with a function of this enzyme in modulation
of progesterone receptor occupancy, but our data also
suggest that another function should exist in the lung.
Indeed, we observed a marked increase in 20α-HSD
expression after birth in both sexes. Interestingly, this
increase just preceded the increase in 21-hydroxylase ex-
pression. Therefore, we propose that 20α-HSD could play
a role related to the glucocorticoid synthesis pathway. This
enzyme can inactivate both the substrate (progesterone)
and the product (DOC) of the 21-hydroxylase [18]. Thus,
the lung 20α-HSD activity should influence glucocorticoid
receptor occupancy.
The coexistence of GC synthesizing and inactivating ac-
tivities in the developing lung strongly suggests regiona-
lization of GC action. Intracrine as well as paracrine GCthe mouse developing lung. Relative expression values were
for each age. The results are the mean of 2 PCR reactions (±SD). Then,
from the values presented in the histograms (B).
Figure 4 Relative expression of 11β-HSD1 and 11β-HSD2 according to sex and time in the mouse developing lung. Relative expression
values were determined by qPCR for 11β-HSD1 (A) and 11β-HSD2 (C) in male and female pools of 3 litters for each age. The results are the mean
of 2 PCR reactions (±SD). Then, the mean of expression (± SEM) for each sex and each age was calculated from the values presented in the
histograms for 11β-HSD1 (B) and 11β-HSD2 (D).
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data. The concept of intracrine action was first demon-
strated for dihydrotestosterone in the prostate [21,22]. It is
defined as the action of newly-formed active steroids
within the cells that synthesized them. As shown in
Figure 6, the 21-hydroxylase activity changes the affinity
of the substrate from progesterone receptor to gluco-
corticoid receptor, while the 20α-HSD activity controls the
availability of active steroids (progesterone and DOC).
Therefore, 20αHSD may be involved in the fine tuning of
both progesterone receptor occupancy, through its impact
on progesterone levels, and glucocorticoid receptor occu-
pancy, through the regulation of the levels of the substrate
(progesterone) and product (DOC) of 21-hydroxylase.
This suggests an optimizing role for 20αHSD in lung
development.
11β-HSD2 is expressed in aldosterone-selective target
cells and prevents illicit occupation of mineralocorticoid
receptor (MR) by GCs [23,24]. A role for mineralocorti-
coids is proposed in lung development [25] where co-
expression of 11β-HSD2 and MR genes were found
[26,27]. MR is proposed to be involved in the control ofreabsorption of pulmonary fluid by ENaC, which is es-
sential to the transition from uterine to aerial life at
birth. However, ENaC is also modulated by glucocorti-
coids in the developing lung [28,29]. The increase in
11β-HSD2 mRNA observed in our experiment occurred
after parturition and correlated well with the beginning
of septation. Therefore, we propose that the process of
septation may require a greater specificity of MR to
mineralocorticoids.
Conclusion
Our data show that expression in the developing lung of
most of the genes involved in the adrenal-like gluco-
corticoid synthesis pathway is maintained beyond GD
15.5. The gene expression results are compatible with
corticosterone formation on GD 15.5, and DOC forma-
tion after GD 15.5, both steroids having the capability to
bind the glucocorticoid receptor. The presence of the
21-hydroxylase protein showed that the fetal lung con-
tains the machinery catalyzing DOC formation from
progesterone, which is present in the fetal circulation.
Co-expression of 21-hydroxylase and 20α-HSD in the
Figure 6 Effects of 21-hydroxylase and 20α-HSD on progester-
one receptor and glucocorticoid receptor occupancy. PROG,
progesterone; PR progesterone receptor; GR, glucocorticoid receptor.Figure 5 21-hydroxylase protein in the mouse developing lung.
A Western blot analysis of the 21-hydroxylase protein is presented
for whole lung protein extracts (50 μg) (panel A) and microsomal
fractions (50 μg of microsomal proteins) (panel B) for the indicated
developmental times. For the study of total protein extracts, levels of
Hsp90β are shown as a loading control. Total protein extracts were
prepared with the lungs from one individual for each time point,
whereas microsomal fractions were prepared using a pool of lungs
from all the fetuses/neonates of one litter for each time point.
Microsomes from adult adrenals were used as control. The proportion
of adrenal microsomal proteins loaded on the gel compared to the
amount loaded for the lungs is indicated (1/1000 = 50 ng microsomal
proteins, 1/500 = 100 ng, and 1/50 = 1 μg). Each pannel corresponds to
a different gel.
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not act as a classical endocrine gland, but is rather a site
of intracrine/paracrine actions.
Methods
Animals and tissue preparation
The protocol and procedures were approved by the ani-
mal care and use committee and the institutional review
board of the Centre de Recherche du CHU de Québec
(CPA-CRCHUQ; protocols no. 2005–156, 2008–071 and
2011–053). All animals were kept under a 12 h light/dark
cycle and received water and feed ad libitum. Balb/c
(Mus musculus) females at the estrus stage and males of
the same strain were mated overnight (16 h). The day of
copulatory plug was considered as GD 0.5 while the
beginning of PN 0 corresponded to parturition. Pregnant
females were kept into individual cages until sacrifice.
All pregnant females were euthanized by CO2 inhalation.
Pups were sacrificed either by decapitation following
hypothermia-induced anesthesia (GD 15.5 to PN 5), or by
intra-peritoneal injection of Euthanyl (PN 6 to PN 16;
pentobarbital sodium, Bimeda-MTC, Cambridge, ON,Canada). Sex of fetuses/neonates was determined by
gonadal morphology. Fetal and neonatal lungs were
individually flash-frozen for use in qPCR and protein
extraction. Adrenals from dams were also collected and
flash-frozen.
Real-time quantitative PCR of target and normalization
genes
For each litter, flash-frozen tissues were pooled accord-
ing to sex. Total RNA was extracted using Tri-reagent
(Molecular Research Center, Cincinnati, OH, USA) ac-
cording to the protocol of the manufacturer. Each RNA
sample was purified on a CsCl gradient [30], using a
TLA 120.2 rotor in an Optima MAX centrifuge (Beckman,
Mississauga, ON, Canada). An aliquot of 4 μg of each total
RNA sample was treated with DNase I (0.25 U/μg of
RNA), and then reversed transcribed using Superscript II
(Life Technologies, Burlington, ON, Canada) and hexame-
ric random primers (pd [N]6, Life Technologies) for
50 min at 42°C in a final volume of 20 μl according to the
protocol of the manufacturer. Reverse transcriptase was
inactivated by heating at 70°C for 15 min. The resulting
cDNAs were diluted tenfold before qPCR analyses. The
same cDNA preparations were used for all of the ana-
lyzed genes. The qPCR reactions were performed on a
LightCycler instrument (Roche, Montreal, QC, Canada)
using LightCycler-FastStart DNA Master SYBR Green I
kits (Roche). After qPCR enzyme activation (10 min,
95°C), PCR cycles were performed as follows: 5 Sec
95°C (denaturation); 5 sec at the annealing temperature;
20 Sec 72°C (elongation); 5 sec at the temperature of
fluorescence intensity reading. The specific primer se-
quences and qPCR conditions are presented in Table 2








Ann. T (°C) Acq. T (°C)
Cyp11a1 NM_019779 ATCCGGGCTTCTTTCCCAATC/GGATGGGGTTCTCAGGCATC 249 64 86
Hsd3b1 NM_008293 TGCCAGGGCATCTCTGTTGTC/TCTGTTCCTCGTGGCCATTCA 220 64 84
Cyp21a1 NM_009995 TCACGACTGTGTCCAGGACTTG/TTCGTCTTTGCCATCCCTTTG 250 67 84
Akr1C18 NM_1340662.2 GCACCATAGGCAACCAGAAC/TCTCATTCATTTCCCAGTGTCTC 312 54 78
Cyp11b1 NM_001033229 CTGGGACAGTCCTCAATGTGA/ATCCGCACATCCTCTTTCTCTT 244 62 87
Hsd11b1 NM_008288 GGCCAGCAAAGGGATTGGAAG/TTTTCCCAGCCAAGGAGGAGA 401 66 85
Hsd11b2 NM_008289 TGGCTGACGTGGGACTGTCT/TTGGAGCAGCCAGGCTTGATA 277 63 87
Gapdh NM_008084 GTCGGTGTGAACGGATTTG/AAGATGGTGATGGGCTTCC 215 61 84
Hmbs NM_013551 GGAATGCATGTATGCTGTGGG/CAGGTACAGTTGCCCATCTT 208 59 85
aAnn. T, annealing temperature; Acq. T, acquisition (fluorescence intensity reading) temperature.
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(21-hydroxylase), Cyp11b1 (11β-hydroxylase), Akr1c18
(20α-HSD), Hsd11b1 (11β-HSD1), Hsd11b2 (11β-HSD2),
Gapdh (glyceraldehyde-3-phosphate dehydrogenase), and
Hmbs (hydroxymethylbilane synthase, transcript variant
1). For each gene, the relative expression levels were
calculated with a standard curve prepared using serial
dilutions of an amplicon in 0.1X reverse transcription
buffer. The use of this buffer for dilutions ensured com-
parable qPCR efficiencies between standard curve sam-
ples and lung cDNA samples, as reported [31]. Hmbs
and Gapdh expression levels were obtained for all the
samples and fed in the GeNorm program to generate a
normalization factor for each sample [32]. For all the
genes, the mean value obtained on GD 19.5 was fixed as
onefold. The suitability of Hmbs and Gapdh as refer-
ence genes for normalization of developing lung sam-
ples had previously been confirmed [33].
Protein extraction
Protein extracts were prepared as previously described
[33], with slight modifications. Briefly, lung tissues were
lysed on ice using a micro-homogenizer (Power max AHS
200, VWR, Ville Mont-Royal, QC, Canada) and 50 to 300
μL of extraction buffer consisting of 50 mM Hepes,
pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM
NaF, 1% (v/v) Triton X-100, 10% (v/v) glycerol, 20 mM β-
glycerophosphate, 8 mM sodium pyrophosphate, and con-
taining a protease inhibitor cocktail (Sigma–Aldrich, St.
Louis, MO, USA; 1 mM AEBSF (4-(2-aminoethyl)benze-
nesulfonylfluoride), 0.8 μM aprotinin, 20 μM leupeptin, 40
μM bestatin, 15 μM pepstatin A, and 14 μM E-64, final
concentrations). Lysates were centrifuged at 16 000 × g
for 20 min at 4°C. Total protein concentrations in super-
natants were determined using the Bio-Rad protein assay
(Bio-Rad, Mississauga, ON, Canada) based on the method
of Bradford. Samples were boiled 3 min in 0.06 M Tris–HCl, pH 6.8, 1% SDS, 3% β-mercaptoethanol, 10% glycerol,
0.025% bromophenol blue and then stored at −20°C
until use.
For microsomes preparations, samples were homoge-
nized by hand in an all-glass Dounce homogenizer fitted
with a B-pestle in ice-cold buffer containing 20% (vol/
vol) glycerol, 1.0 mM EDTA, and 4 mM potassium
phosphate, pH 7.0 (KPBS). Homogenates were centrifuged
at 12,000 × g for 20 min to remove cell debris. The result-
ing supernatants were centrifuged at 105,000 × g for
60 min. The pellets were resuspended in KPBS and
centrifuged again at 105,000 × g for 60 min. The resulting
pellets were resuspended in the Triton X-100-containing
extraction buffer described above, and saved as micro
somes-enriched extracts. Protein concentrations in micro-
somal fractions were determined as described above.
Western blot analysis and specific antibodies
Lung protein extracts were separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
using 10% (wt/vol) acrylamide. Then, proteins were trans-
ferred to a nitrocellulose membrane (Bio-RAD). Mem-
branes were blocked 2 h at room temperature with 5%
(w/v) fat-free milk powder in PBS (1× PBS: 137 mM
NaCl, 2.68 mM KCl, 4.30 mM Na2HPO4, 1.47 mM
KH2PO4) containing 0.1% (v/v) Tween 20. Membranes
were then incubated 1 h at room temperature with
either a mouse anti-rat 21-hydroxylase monoclonal anti-
body (1:3000; Chemicon International Inc., ON, Canada)
or a rabbit anti-Grp78 (Hsp90β) polyclonal antibody
(1:100; Santa Cruz Biotechnology, Santa Cruz, CA, USA)
in 1X PBS/Tween 20 containing 2.5% (w/v) fat-free milk.
After washing in 1X PBS/Tween 20, bound antibodies
were visualized with horseradish peroxidase-conjugated
goat anti-mouse or goat anti-rabbit antibodies (1:5000;
Jackson ImmunoResearch Laboratories, West Grove, PA,
USA) using a Lumi-Light Western Blotting Substrate
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http://www.biomedcentral.com/1756-0500/7/119(Roche Applied Science). Then, antibodies were removed
by washing in 62.5 mM Tris–HCl, pH 6.8, 2% (w/v) SDS,
0.7% (v/v) β-mercaptoethanol for 30 min at 60°C. The strip-
ping efficiency was validated with a Lumi-Light Western
Blotting Substrate. Membranes were first used to detect 21-
hydroxylase, stripped, and then re-probed for Hsp90β.
Statistics
The effects of age and sex on target gene expression data
was assessed by a randomized-block 2-way ANOVA,
male and female pools of the same litter being matched.
The age of the studied litters was considered as a fixed fac-
tor. To ensure that assumptions of normality and homo-
geneous variances were respected, the dependent variable
(expression) was either untransformed (P450scc, 20α-
HSD), transformed into its natural log (21-hydroxylase,
11β-HSD1 and 11β-HSD2) or transformed into its re-
ciprocal (3β-HSD1). For each gene, comparisons be-
tween the mean expression values (calculated with data
from both sexes) at specific age-points were performed
using the Bonferroni test on selected pairs. The differ-
ences were considered statistically significant when p <
0.05, whereas for 0.1 > p > 0.05, the differences were
considered to present a significant trend.
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